Literature DB >> 29508182

Development and Validation of a Prediction Model for Postoperative Peritoneal Metastasis After Curative Resection of Colon Cancer.

Hiroshi Nagata1, Soichiro Ishihara2, Koji Oba3,4, Toshiaki Tanaka5, Keisuke Hata5, Kazushige Kawai5, Hiroaki Nozawa5.   

Abstract

BACKGROUND: Detection of peritoneal metastasis remains challenging due to the limited sensitivity of current examination methods. This study aimed to establish a prediction model for estimating the individual risk of postoperative peritoneal metastasis from colon cancer to facilitate early interventions for high-risk patients.
METHODS: This study investigated 1720 patients with stages 1-3 colon cancer who underwent curative resection at the University of Tokyo Hospital between 1997 and 2015. The data for the patients were retrospectively retrieved from their medical records. The risk score was developed using the elastic net techniques in a derivation cohort (973 patients treated in 1997-2009) and validated in a validation cohort (747 patients treated in 2010-2015).
RESULTS: The factors selected using the elastic net approaches included the T stage, N stage, number of examined lymph nodes, preoperative carcinoembryonic antigen level, large bowel obstruction, and anastomotic leakage. The model had good discrimination (c-index, 0.85) and was well-calibrated after application of the bootstrap resampling method. Discrimination and calibration were favorable in external validation (c-index, 0.83). The model presented a clear stratification of patients' risk for postoperative peritoneal recurrence, and decision curve analysis showed its net benefit across a wide range of threshold probabilities.
CONCLUSIONS: This study established and validated a prediction model that can aid clinicians in optimizing postoperative surveillance and therapeutic strategies according to the individual patient risk of peritoneal recurrence.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29508182     DOI: 10.1245/s10434-018-6403-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  2 in total

1.  TMEM100 Modulates TGF-β Signaling Pathway to Inhibit Colorectal Cancer Progression.

Authors:  Huixia Li; Chuan Cheng; Weibo You; Jiujian Zheng; Jie Xu; Peng Gao; Jianping Wang
Journal:  Gastroenterol Res Pract       Date:  2021-08-11       Impact factor: 2.260

2.  Clinical Value of PET.CT Based on Big Data in Colorectal and Peritoneal Metastatic Cancer.

Authors:  Lili Xiang; Chuanhua Yang; Wenneng Liu; Dong Li; Zongze Jiang; Huijun Zhou
Journal:  Contrast Media Mol Imaging       Date:  2022-09-30       Impact factor: 3.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.